COVID-19 Vaccination Updates
Johnson and Johnson Vaccine - Effective April 23, 2021, CDC and FDA recommend that use of the Janssen COVID-19 Vaccine resume in the United States. However, women younger than 50 years old should be made aware of a rare risk of blood clots with low platelets following vaccination and the availability of other COVID-19 vaccines where this risk has not been observed. Read the CDC/FDA statement. On April 13th, the FDA and CDC, out of an abundance of caution, recommended pausing administration of the Johnson and Johnson (J&J) COVID-19 vaccine. Click here to read the MedStar Health Provider Alert for more details and recommendations. For the most up-to-date information regarding the J&J vaccine, visit:
CDC website at CDC.gov/Vaccines/Covid-19/Info-By-Product/Janssen
FDA website at FDA.gov/Emergency-Preparedness-and-Response/Coronavirus-Disease-2019-Covid-19/Janssen-Covid-19-Vaccine
District of Columbia Vaccine Information - For the most up-to-date information on vaccinations in the District of Columbia, visit Coronavirus.DC.gov/Vaccine
Provider Newsletters
To view the MFC-DC Provider Newsletter, click on the link below:
